xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">
http://ehpnet1.niehs.nih.gov/docs/2001/109-6/niehsnews.html
NIEHS News
Environmental Health
Perspectives Volume 109, Number 6, June 2001
NIEHS Investigates Links between Children, the Environment, and
Neurotoxicity
|

Photo credit: Reuther/EHP
|
Autism, attention deficit/hyperactivity disorder (ADHD), and other
neurodevelopmental, learning, and behavioral disorders may by some estimates
affect as many as 1 in 6 U.S. children--or some 12 million children--according
to a U.S. Census Bureau report published in the journal Pediatrics in
1993. The consequences of these disorders can be tragic, their familial, societal,
and economic costs immense, and the resulting disabilities lifelong. While
exposure to certain environmental chemicals is recognized or suspected of
causing neurodevelopmental deficits, the origins of most of these disorders are
still unknown. Today scientists are focused on investigating the possibility
that at least some of the brain disorders that affect many children are
produced when environmental triggers interact with genes in susceptible
individuals.
Kenneth Olden, director of the NIEHS, was a keynote speaker at the 2001
annual conference of the Learning Disabilities Association of America (LDA),
held 7-9 February 2001 in New York City. The LDA is a volunteer, parent-led
organization dedicated to pursuing advocacy initiatives that focus on preventing
learning disabilities and supporting education and research on these
conditions. In his address, Olden referred to a quote by Judith Stern of the
University of California at Davis--"genetics loads the gun, but
environment pulls the trigger"-- that eloquently illustrates the current
scientific thinking that genetic susceptibility and exposure to environmental
toxicants interact in the individual to produce disease. Said Olden,
"Current gaps in our knowledge keep us from preventing the loaded gun from
going off again and again." Understanding these gene-environment
interactions may be the key to finding the cause of many illnesses with no
known etiology, including some neurodevelopmental disabilities.
Many observers believe that reducing the burden that environmental threats
cause in children's health will take a major concerted effort involving
strongly committed collaborations, perhaps between groups such as the LDA and
the NIEHS. In such a scenario, advocacy leaders such as the LDA could inform
the research agenda by bringing forward the concerns and priorities of the
children and parents who are directly affected by neurodevelopmental disorders.
In turn, the NIEHS could support and provide the sound scientific research data
that make the advocacy efforts more compelling and effective. As LDA member
Audrey McMahon points out, "This marriage between brain sciences research
with advances in environmental neurotoxicology and community participation is
the only model that can guide us to a new appreciation of needs and
solutions."
Presentations at the LDA annual conference illustrated the need for
increased efforts in research on the effects of environmental toxicants on
brain development and behavior. Annette Kirshner, a program administrator in
the Organs and Systems Toxicology Branch of the NIEHS Division of Extramural
Research and Training, pointed out that the NIEHS dedicated over 10% of its
2000 extramural research budget to supporting research in children's
environmental health.
According to Kirshner, one series of NIEHS-supported studies showed that
exposure to an environmental toxicant early in development may result in
behavioral and cognitive effects later in life. Kirshner noted that Herbert
Needleman and colleagues at Pennsylvania's University of Pittsburgh School of
Medicine found that lead exposure early in life is associated with increased
risk for antisocial and delinquent behavior, high school failure, and reading
deficits in young adults. In a paper published in the 7 February 1996 issue of
the Journal of the American Medical Association, Needleman and
colleagues estimated that 15% of delinquency is attributable to lead exposure.
Some scientists dispute this conclusion, because lead exposure is also
correlated with other factors, such as poverty, that are associated with
delinquency. More research is needed before it is known whether lead and other
environmental toxicants are involved in producing changes in children's
behavior, temperament, and ability to learn.
ADHD: On the Rise?
ADHD is a developmental disability characterized by inattention,
impulsivity, and hyperactivity. It is one of the most commonly diagnosed
behavioral conditions of childhood. The NIH consensus statement on the
diagnosis and treatment of ADHD, published in 1998, estimated that at least
3-5% of U.S. children have the disorder. Moreover, the incidence of ADHD may be
on the rise.
A survey of office-based physicians published in the December 1999 issue of
the Archives of Pediatrics and Adolescent Medicine by researcher Julie
Magno Zito and colleagues at the University of Maryland in Baltimore found that
all ADHD- related visits between 1989 and 1996 increased by 90% in children,
from 1.9% of total physician visits to 3.6%. The use of stimulants such as
Ritalin to treat ADHD in children rose 14% during this same period, according
to the same study. Such increases in office visits and stimulant treatment may
be explained by several factors, including a greater awareness of the disorder,
a greater acceptance of medication to treat behavioral disorders, and a
broadening of the definition of ADHD. But it is also possible that such
increases may be explained by growth in the actual incidence rate.
The causes of ADHD are largely unknown. Some studies have shown that genetic
factors may play a role, while others suggest that substances in the
environment may have an effect. A paper by Deborah C. Rice of the U.S.
Environmental Protection Agency, published in the June 2000 issue of EHP
Supplements, suggests that lead and polychlorinated biphenyls might play a
role. To investigate further, the NIEHS is supporting a large, comprehensive
study of children with ADHD, led by Andrew Rowland, a research fellow in the
Epidemiology Branch of the NIEHS Division of Intramural Research.
The study uses ADHD diagnostic and epidemiologic criteria to screen all
children attending elementary schools in Johnston County, North Carolina. About
83% of all parents of elementary schoolchildren agreed to their child's teacher
completing a form about their child's attention and behavior. The researchers
then interviewed mothers of children who appeared to have symptoms of ADHD
along with a randomly selected group of controls. Children who met the
diagnostic criteria for ADHD by showing symptoms and impairment at school and
home were considered cases. In all, about 550 cases and 550 controls were
interviewed, making this one of the largest population-based studies of ADHD to
date.
Schools are required to conduct learning disability evaluations and design
classroom accommodations for children who are diagnosed with ADHD. At the time
the study was first proposed, Johnston County school officials were worried
that they would not have the financial or staff resources to do the additional
testing or required classroom accommodations if the study uncovered many new
cases of ADHD. But the team was able to devise a way to measure ADHD incidence
in a way that was scientifically sound while addressing the school system's
concerns.
The researchers worked with the schools to form a coalition of local
organizations including the county health and mental health departments, the
state mental health department, the county office of juvenile justice, the
county department of social services, and the University of North Carolina at
Chapel Hill Department of Psychiatry to work with children identified by the
study. A grant by the Kate B. Reynolds Charitable Trust allowed the coalition
to hire a health educator to show parents, teachers, and medical professionals
how to work more effectively with children with ADHD and to help coordinate a
mobile clinic of university doctors who were available to treat and refer
children identified by the study. The study involved collaboration between the
many interested groups. As Rowland describes it, "We were only able to do
the study by working closely with the schools and the community. Without the
close cooperation of the schools and the community partners, we would not have
been able to do the study, and the study would have failed
scientifically." A preliminary description of the study was published in
the September-October 2000 issue of Neurotoxicology and Teratology.
An important preliminary finding of the Johnston County study is that many
children being treated with stimulant medications continue to meet the full
diagnostic criteria for ADHD despite being treated, says Rowland. This may
indicate deficiencies in clinical followup and a lack of coordination between
health care providers, parents, and schools. The second phase of the study aims
to assess whether preterm delivery is related to the risk of ADHD and whether in
utero exposures to cigarette smoke, alcohol, and other environmental agents
are risk factors for ADHD.
Seeking an Understanding of Autism
The NIEHS is also interested in exploring the potential role of
environmental factors in autism. Autism refers to a group of developmental
disorders (also referred to as autism spectrum disorders) that includes
autistic disorder, atypical autism, and Asperger syndrome. Children with these
disorders display deficits in social interaction and communication and the
presence of repetitive and/or restrictive behaviors or interests. It is not
known how many children in the United States have autistic disorders, and
estimates vary widely. Recent research from the Centers for Disease Control and
Prevention (CDC) indicates that as many as 2 out of every 1,000 children may be
affected by some form of these disorders; a different analysis of data from the
1992-1994 National Health Interview Surveys, part of a CDC study to find the
prevalence of many different diseases, showed that 4 out of every 10,000 U.S.
children were reported by their parents to have been diagnosed with autism.
Whatever the numbers, they do not adequately convey the emotional, financial,
and societal toll that autism can take on families and communities.
The NIEHS is supporting several research efforts to investigate the role
that environmental factors may have in causing autism in children. Cindy Lawler
is the extramural program staff representative to the NIH Autism Coordinating
Committee, a group of NIH directors and institute representatives charged with
enhancing the quality, pace, and coordination of efforts across the NIH to
prevent and find a cure for autism. Eventually this committee will be replaced
with an expanded committee that includes all the relevant NIH institutes, other
agencies such as the CDC, and parent representatives.
The NIEHS has welcomed input from autism advocacy and parent organizations.
Parent representatives meet once per year with the committee to discuss
upcoming NIH autism initiatives, to highlight important findings in autism, and
to seek parents' input into the research agenda. This yearly conference is
sponsored by all member institutes on the committee, including the National
Institute of Mental Health, the National Institute of Neurological Disorders
and Stroke, the National Institute on Deafness and Other Communication
Disorders, and the National Institute of Child Health and Human Development. In
the summer of 2001 the NIEHS and the National Institute of Child Health and
Human Development will take the lead as primary sponsors of a meeting focusing
on cellular and molecular mechanisms in autism and related neurodevelopmental
disorders.
A meeting held on 23 October 2000 at the NIEHS illustrates how exchanges
between parents/advocates and researchers can result in increased understanding
of the needs of the people affected by autism and fruitful collaboration on
shaping research priorities. Representatives from the NIEHS and several
advocacy groups met to discuss ways to increase research efforts, improve
clinical testing, and reduce or eliminate the environmental toxic exposures
that may cause or aggravate neurodevelopmental conditions. Various research
avenues were discussed, including the possibility that ethylmercury, a
component of thimerosal, which is used in childhood vaccines as a preservative,
may be a trigger of autism in susceptible individuals. Says Sallie Bernard, executive
director of Sensible Action For Ending Mercury-Induced Neurological Disorders,
a parent group advocating for the elimination of mercury from vaccines and
other products, "The appearance of signs of autism occurs in a significant
number of children who develop and behave normally until being immunized."
The NIEHS is supporting studies to investigate the pharmacokinetics of
ethylmercury in vaccines. (Ethylmercury is already being phased out of
childhood vaccines in response to concerns about its potential toxicity,
particularly whether it can enter the brain to the same extent as the related
compound methylmercury.)
To further expand its research portfolio on children's neurodevelopmental
disorders, the NIEHS is jointly sponsoring a new initiative in autism research.
Along with other relevant institutes of the NIH, the NIEHS has issued a program
announcement titled "Research on Autism and Autism Spectrum
Disorders" (PA-01-051). In addition, the existing NIEHS and Environmental
Protection Agency-sponsored network of Centers for Children's Environmental
Health and Disease Prevention Research will be expanded from the 8 currently
funded to 10 or 11. These new centers will focus on addressing developmental
disorders including those of neurologic origin.
Building a Data Framework
One reason why it is not known whether ADHD, autism, and other
neurodevelopmental disabilities are related to environmental factors is because
so little is known about the toxicity of many chemicals present in the
environment. Evidence of the need for testing chemical effects on brain
development was presented in the report Polluting Our Future: Chemical
Pollution in the U.S. That Affects Child Development and Learning,
published jointly by the LDA, the National Environmental Trust, and Physicians
for Social Responsibility. The report presents data from federal sources such
as the Toxics Release Inventory and other national databases available through
the Emergency Planning and Community Right-to-Know Act of 1986.
The data show that 1.2 billion pounds of chemicals were reported by
industries to be released into air and water in 1998. Of these, an estimated
53% are known or suspected agents in affecting neurologic or developmental
function. These figures may actually be much higher because, says the report,
it has been estimated that only 5% of chemicals released into the environment
are reported to the national databases. Because most of these chemicals are not
tested for their effect on the developing brain, it is possible that many
neurodevelopmental and learning disabilities are due to children's exposure to
these potential neurotoxicants. The LDA is calling for regulatory agencies to
support testing of the effects of food additives, pesticides, drugs, and other
industrial chemicals on the developing brain. In the meantime, as Olden
describes it, "We live in a state of toxic ignorance."
The NIEHS is positioned to play a central role in investigating the
relationship between learning disabilities of unknown cause and environmental exposures
during brain development. One promising area of research is new technology
using DNA microarrays, which offers the opportunity to examine the interaction
between toxicants and genetic susceptibility at the molecular level. This
technology will yield a database of toxicity fingerprints of known toxicants
against which chemicals of unknown toxicity can be compared. This line of
research has been established at the NIEHS as the National Center for
Toxicogenomics and is described on their Web site at http://www.niehs.nih.gov/nct/home.htm.
The eventual compilation of such a database will be welcome news for both the
advocacy and research communities who are concerned with children's
environmental health. -Luz Claudio
NTP Center Reports on Phthalate Concerns
An expert panel convened by the National Toxicology Program (NTP) Center for
the Evaluation of Risks to Human Reproduction (CERHR) has announced that after
intensive evaluation of seven phthalates, only one presents a serious concern
to human reproduction or development. Di(2-ethylhexyl) phthalate, or DEHP, is
considered of serious concern for the possibility of adverse effects on the
developing reproductive tract of male infants exposed to high concentrations of
the phthalate through medical procedures using phthalate-containing equipment
such as intravenous bags and tubing.
The center is currently preparing the NTP Center Report on Phthalates,
due for release late this summer. Michael Shelby, director of the CERHR, says,
"The report will provide an independent, scientifically rigorous document
for use by all stakeholders in any further discussions that might ensue on the
reproductive effects of these seven phthalates."

Created in 1998 by the NTP and the NIEHS to assess the human reproductive
health risks associated with exposures to environmental chemicals, the CERHR
announced in April 1999 that it was turning its attention to the risks posed by
seven phthalates, which are used as plasticizers in a spectrum of polyvinyl
chloride-based products ranging from flexible tubing to plastic toys. The
phthalates selected for evaluation included DEHP, butyl benzyl phthalate (BBP),
di-n-butyl phthalate (DBP), di-isononyl phthalate (DINP), di-isodecyl
phthalate (DIDP), di-n-hexyl phthalate (DnHP), and di-n-octyl
phthalate (DnOP). The chemicals were selected based on their high production
volume, the number of people potentially exposed to them, their use in products
especially intended for children (such as toys), and evidence of reproductive
or developmental toxicity. To evaluate the seven phthalates, the center brought
together a panel of 16 experts in toxicology, epidemiology, and other relevant
fields from government, research, and academic institutions from across the
United States.
Over a period of 15 months, the panel evaluated the published data for each
phthalate to determine whether or not it is likely to present a risk to human
reproduction or development. The panel considered the amount and quality of
data available in two primary areas: human exposures to the phthalate in
question and experimental evidence for its reproductive and developmental
toxicity.
The panel assigned minimal concern to DINP for adverse developmental
outcomes in children exposed in utero and for adverse effects on the
reproductive system of exposed adults. There was, however, low concern for
potential developmental and reproductive health effects in children who might
be exposed through mouthing toys or other DINP-containing objects. For BBP,
DnOP, DBP, and DIDP, there was minimal or negligible concern for adverse
effects on the reproductive system of exposed adults or for potential
developmental and reproductive health effects of exposed children. For one
chemical, DnHP, there were insufficient data for the panel to reach any
conclusions. The panel had only minimal concern that current estimated
exposures to DEHP would adversely affect the reproductive system of adults.
Following initial publication of the panel's findings in October 2000, the
NTP and the CERHR have gathered public comments that will be incorporated into
the NTP Center Report on Phthalates, along with newly available data
published since the panel's last meeting. The final report will also include
critical data needs and a list of planned or ongoing studies that address those
needs.
Two studies released since the panel completed its reports have provided
interesting postscripts to their findings. First is a report by scientists from
the NTP and the Centers for Disease Control and Prevention, published in the
October 2000 issue of EHP, which found that the highest DBP metabolite
concentrations in a large study sampling were found in women of reproductive
age. (This study also provides the first measure of phthalate metabolites in
the body; other studies, including those reviewed by the panel, were
calculations of doses based on exposure data.) Second is an article published
in the December 2000 issue of the Journal of Pediatric Surgery by
scientists at the University of Heidelberg medical complex in Mannheim,
Germany, which firmly bolsters the panel's concern that premature infants are
exposed to high doses of DEHP through the use of medical equipment made of phthalate-containing
polyvinyl chloride plastic. The German authors are now investigating whether
the high DEHP doses they observed are related to the hepatobiliary dysfunction
common with tube-feeding.
The final report will be available to federal and state regulatory and
health agencies, nongovernmental organizations, industry groups, and the
public, and will be posted on the CERHR Web site at http://cerhr.niehs.nih.gov/.
-Susan M. Booker
|
Seven Phthalate Esters Tested and Their
Uses
|
|
Chemical
|
Uses
|
- di(2-ethylhexyl)
phthalate (DEHP)
|
Building products, food packaging, children's products, medical equipment
|
- butyl benzyl phthalate
(BBP)
|
Vinyl tile, food conveyor belts, artificial leather, traffic cones
|
- di-n-butyl phthalate
(DBP)
|
Latex adhesives, cellulose plastics, dyes
|
- di-isononyl phthalate
(DINP)
|
Garden hoses, shoes/shoe soles, toys, construction materials
|
- di-isodecyl phthalate
(DIDP)
|
Automobile undercoating, wires and cables, shoes, carpet backing, pool
liners
|
- di-n-hexyl phthalate
(DnHP)
|
Automobile parts, tool handles, dishwasher baskets, flooring, tarps, flea
collars
|
- di-n-octyl phthalate
(DnOP)
|
Flooring and carpet tile, canvas tarps, notebook covers
|
Last
Updated: Mon, 2001 July 02
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.